CIK 0001739104
- Large accelerated filer
Elanco Animal Health Inc
Sign in to watch- Ticker
- ELAN
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 825497352
- Phone
- +1 877-352-6261
- Business address
- 450 ELANCO CIRCLE, INDIANAPOLIS, IN, 46221
- Open-market buys, last 90 days
- $935,920
- in 1 filing
- Open-market sales, last 90 days
- $100,050
- in 1 filing, $100K under 10b5-1 plans
Net +$835,870. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-07-29 | Kurzius Lawrence Erik Director | Grant or award · Deferred Stock Units | +452.45 | $20.26 | $9K | 11,712.7 |
| 2022-07-29 | BILBREY JOHN P Director | Grant or award · Deferred Stock Units | +436 | $20.26 | $9K | 11,112.82 |
| 2022-07-01 | Correia de Simas Jose Manuel SEE REMARKS | Shares withheld for taxes | −2,172 | $20.62 | $45K | 19,607 |
| 2022-07-01 | Kirberger Marcela A. SEE REMARKS | Shares withheld for taxes | −1,868 | $20.62 | $39K | 17,287 |
| 2022-06-30 | HOOVER R DAVID Director | Grant or award · Deferred Stock Units | +543.39 | $19.63 | $11K | 22,219.07 |
| 2022-06-30 | BILBREY JOHN P Director | Grant or award · Deferred Stock Units | +449.99 | $19.63 | $9K | 10,676.82 |
| 2022-06-30 | Kurzius Lawrence Erik Director | Grant or award · Deferred Stock Units | +466.97 | $19.63 | $9K | 11,260.25 |
| 2022-05-31 | HOOVER R DAVID Director | Grant or award · Deferred Stock Units | +450.07 | $23.70 | $11K | 21,675.69 |
| 2022-05-31 | BILBREY JOHN P Director | Grant or award · Deferred Stock Units | +372.71 | $23.70 | $9K | 10,226.83 |
| 2022-05-31 | Kurzius Lawrence Erik Director | Grant or award · Deferred Stock Units | +386.78 | $23.70 | $9K | 10,793.27 |
| 2022-05-20 | HOOVER R DAVID Director | Purchase | +10,000 | $23.33 | $233K | 125,000 |
| 2022-05-11 | BILBREY JOHN P Director | Purchase | +10,000 | $22.03 | $220K | 34,222 |
| 2022-04-29 | HOOVER R DAVID Director | Grant or award · Deferred Stock Units | +421.44 | $25.31 | $11K | 21,225.62 |
| 2022-04-29 | Kurzius Lawrence Erik Director | Grant or award · Deferred Stock Units | +362.18 | $25.31 | $9K | 10,406.49 |
| 2022-04-29 | BILBREY JOHN P Director | Grant or award · Deferred Stock Units | +349.01 | $25.31 | $9K | 9,854.12 |
| 2022-04-01 | Modi Rajeev A. SEE REMARKS | Grant or award | +34,457 | 34,457 | ||
| 2022-03-31 | BILBREY JOHN P Director | Grant or award · Deferred Stock Units | +338.57 | $26.09 | $9K | 9,505.11 |
| 2022-03-31 | Kurzius Lawrence Erik Director | Grant or award · Deferred Stock Units | +351.35 | $26.09 | $9K | 10,044.32 |
| 2022-03-31 | HOOVER R DAVID Director | Grant or award · Deferred Stock Units | +408.84 | $26.09 | $11K | 20,804.18 |
| 2022-03-05 | Simmons Jeffrey N PRESIDENT, CEO AND DIRECTOR | Shares withheld for taxes | −10,688 | $27.95 | $299K | 752,986 |
Page 29 of 35 · 697 trades